Anaphylaxis is rare due to CoronaVac in a population of healthcare workers

BACKGROUND: CoronaVac, the first coronavirus disease 2019 vaccine administered in our country, was found safe in clinical trials. OBJECTIVE: We aimed to reveal the rate and features of CoronaVac vaccine-associated allergic reactions among vaccinated healthcare workers (HCWs) in real-life. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Öztürk, Betül Özdel, Akdemir, İrem, Azap, Alpay, Çelik, Gülfem, Bavbek, Sevim, Mungan, Dilşad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia Pacific Association of Allergy, Asthma and Clinical Immunology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669466/
https://www.ncbi.nlm.nih.gov/pubmed/36452009
http://dx.doi.org/10.5415/apallergy.2022.12.e35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669466/
https://www.ncbi.nlm.nih.gov/pubmed/36452009
http://dx.doi.org/10.5415/apallergy.2022.12.e35

Ejemplares similares